This page shows the latest Logimax news and features for those working in and with pharma, biotech and healthcare.
Last year the Italian firm paid $300m to purchase AstraZeneca’s European rights to cardiovascular drug Seloken and related combination Logimax.
Italian pharma firm obtains Seloken and Logimax. Recordati has picked up the rights to two of AstraZeneca’s hypertension treatments as part of a $300m (270m) deal. ... The agreement sees the Milan-based pharmaceutical group acquire rights to AZ’s
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...